Evvy

Get innovative vaginal healthcare, powered by our state-of-the-art Vaginal Microbiome Test.

Health and bio

Latest funding

$40M Series B+ · September 15, 2026

Led by Catalio · Source: siliconangle.com

Total raised: $59M across 3 sourced rounds

All 3 rounds ↓

Website: evvy.com.

X: @EvvyBio · 488 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Artificial Intelligence (AI), Biotechnology, Health Care, Personal Health, Precision Medicine.

Stage: Series B+.

Based in: New York, United States.

Founded: 2020.

Total raised: $59M in 3 sourced rounds.

Last round: Sep 15, 2026 · 61 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@EvvyBio · created Jan 19, 2021 (5 years old) · 488 followers

Website registeredJan 7, 2002 (24 years old)

About Evvy

Our clinical care platform includes Rx for bacterial vaginosis (BV), yeast infections, aerobic vaginitis, fertility and more. Trusted by 100,000+ users.

TIMELINE · MONEY RAISED

Evvy | 176 days from X account to first raise on record

@EvvyBio·Raised $59M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Sep 15, 2026	Series B+	$40M	CCatalio	siliconangle.com
Sep 27, 2023	Series A	$14M	LLeft Lane Capital	fundraisingfox.com
Jul 14, 2021	Seed	$5M	GGeneral Catalyst	finsmes.com

Timeline

January 19, 2021
X account created
January 7, 2002
Website created

Founders and team

PJ
Priyanka Jain Co-Founder & CEO

LinkedIn · source: evvy.com
LB
Laine Bruzek Founder

LinkedIn
PN
Pita Navarro Founder

LinkedIn
KM
Kate McLean Chief Medical Officer

Investors

Companies like Evvy

WWinx Health (fka Stix)
CCoologics$3M Seed · Apr 2025
MMicrogenesis
SScience$230M Series B+ · Mar 2026
DDoppel$70M Series B+ · Nov 2025
EEarSmartAIPre Seed · May 2026

Other companies backed by Catalio

SStar Therapeutics$200M Series B+ · Oct 2026
OOpenEvidence$250M Series B+ · Sep 2026
EEnveda$311M Series B+ · Sep 2026
CClaris Bio$118M Series B+ · Jul 2026
AAdvanCell$315M Series B+ · Jul 2026
LLeo Cancer Care$65M Series B+ · Jul 2026

Catalio portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/evvy (get a free API key).